The Pharmacist e-Link™ Continuing Education Center is designed
to provide you with expanded online access to the highest quality
of continuing education on a complimentary basis, through the
convenience of the MyCECity™ Online Learning Management System.
This program will outline how to train an on-staff,
third party specialist and capitalize on the independent
pharmacy's unique ability to proactively address third party
issues with patients. The result-patients get the best value
for their dollar and the pharmacy.
This program is supported by an educational grant from Merck & Co., Inc.
Other
Featured CE
New and Spotlighted Programs in the Pharmacist e-Link Library
Click the activity title below to login and enter the activity.
A Pharmacist's Guide to Counterfeit Prevention
Reports of counterfeit medications infiltrating the distribution chain have become widespread and undermine the confidence of patients in the medications they are taking, their physician, and pharmacist. It is estimated that five to eight percent of drugs worldwide are counterfeit. Pharmacists are able to address patient concerns and questions about counterfeit medications and are important to allay patient's concerns and restore their faith in the product and their health care providers.
The program is supported by an educational grant from Pfizer, Inc.
The Skinny on Fatty Acids: The Efficacy of Omega-3s The purpose of this activity is to provide information regarding available types and sources of omega-3 fatty acids. These include over the counter plant-and fish oil-based supplements and a newly approved prescription product. It is important that pharmacists are aware of the appropriate treatment options when advising patients with hypertriglyceridemia or those otherwise at risk for coronary heart disease. This program is supported by an educational grant from Reliant Pharmaceuticals.
Educating your Respiratory Patients on their Devices:
Pharmacists Can Make It Work It is important that pharmacists understand their continuous role in the appropriate delivery of inhaled medications so that their patients have the best outcome from the use of these medications. This program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Strategies in the Prevention of Cardiovascular Events and Mortality in the High-Risk Older Population Cardiovascular disease (CVD) is a substantial US healthcare burden, with about 40% of all US deaths annually as a result of cardiovascular events. Current initiatives examine not only pharmacologic treatment, but also lifestyle changes that are focused on the prevention of CVD in the elderly. This program is supported through an educational grant from Wyeth and King Pharmaceuticals.
Bioequivalence, Therapeutic Equivalence, & Clinical Case Management in Thyroid Disease Studies consistently show that as many as 40% of patients with hypo- or hyper-thyroidism are not well managed by physicians. These studies each used thyroid-stimulating hormone (TSH) as the clinical marker of thyroid dysfunction. Studies have also shown that the clinical consequences of abnormal TSH levels include cardiovascular and lipid risks; miscarriage, fetal death and lower IQs; and particular risks for patients with cancer. This program is supported by an educational grant from Abbott Laboratories.
Pharmacist e-Link CE Spotlight is sent by Pharmacist e-Link™, located at
307 Seventh Avenue, 24th Floor, New York, NY 10001.
Pharmacist e-Link never sends unsolicited mail.
If you wish to unsubscribe from further mailings, please
click here.
